Skip to search formSkip to main contentSkip to account menu

1592U89

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2000
Highly Cited
2000
SummaryAbstractAbacavir is a carbocyclic 2′-deoxyguanosine nucleoside analogue. It is metabolised intracellularly to a 2… 
Highly Cited
1999
Highly Cited
1999
ABSTRACT Abacavir (1592U89) is a nucleoside analog reverse transcriptase inhibitor that has been demonstrated to have selective… 
Highly Cited
1999
Highly Cited
1999
ABSTRACT Abacavir (formerly 1592U89) is a potent 2′-deoxyguanosine analog reverse transcriptase inhibitor that has been… 
1999
1999
Objectives. To evaluate the pharmacokinetic features, safety, and tolerance of abacavir, given alone and in combination with… 
1998
1998
ABSTRACT The use of combinations of anti-human immunodeficiency virus (anti-HIV) agents targeted to different molecular targets… 
1998
1998
L'invention concerne des combinaisons therapeutiques de (-)-(1S, 4R)-4-[2-amino-6- (cyclopropylamino)-9H-purin-9-yl] -2… 
Highly Cited
1997
Highly Cited
1997
The carbocyclic nucleoside 1592U89 is a selective inhibitor of the human immunodeficiency virus (HIV), targeting the reverse… 
Review
1996
Review
1996
Carbocyclic nucleosides have been the focus of much recent attention in the development of new antitumor and antiviral… 
1996
1996
(57) Abstract: The present invention has an anti-HIV activity (1S, 4R) - cis -4- [2-amino-6- (cyclopropylamino) -9H- purin-9-yl… 
1996
1996
L'invention concerne des combinaisons therapeutiques de (1S,4R)-cis-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene…